A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes (NCT05536804)

🧪 Interventions in This Study

• Tirzepatide (DRUG)
• Placebo (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (27 Sites)

Showing the first 25 of 27 sites.

• Valley Clinical Trials, Inc. — Northridge, California
• University of Colorado Anschutz Medical Campus — Aurora, Colorado
• Kidney Associates of Colorado — Denver, Colorado
• American Health Network of Indiana, LLC - Avon — Avon, Indiana
• American Health Network of Indiana, LLC - Greenfield — Greenfield, Indiana
• Indiana University Health University Hospital — Indianapolis, Indiana
• American Health Network of Indiana, LLC - Muncie — Muncie, Indiana
• Arcturus Healthcare , PLC, Troy Internal Medicine Research Division — Troy, Michigan
• University of Washington Medical Center - Montlake — Seattle, Washington
• Providence Medical Research Center - Spokane — Spokane, Washington
• Klinik Landstraße — Vienna,
• Zentrum für klinische Studien Dr Hanusch Gmbh — Vienna,
• Klinik Hietzing — Vienna,
• LMC Clinical Research Inc. (Barrie) — Barrie,
• LMC Clinical Research Inc. (Thornhill) — Concord,
• Centre intégré universitaire de santé et de services sociaux de l'Estrie Centre Hospitalier Universitaire -T — Sherbrooke,
• Toronto General Hospital — Toronto,
• Fadia El Boreky Medicine — Waterloo,
• Aarhus Universitetshospital, Skejby — Aarhus,
• Centro de Investigación y Gastroenterología — Cuauhtémoc,
• Investigación Nefrológica — Cuernavaca,
• Health Pharma Professional Research S.A. de C.V: — Mexico City,
• Grupo Medico Camino Sc — Mexico City,
• Caimed Investigacion En Salud S.A. de C.V. — Mexico City,
• Instituto Nacional de Cardiologia Ignacio Chavez — México,

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Overweight

• A Research Study to Compare Blood Levels of Two Different Versions of Cagrilintide in Adults With Excess Body Weight — Tempe, Arizona
• A Research Study on How Well Different Doses of the Medicine NNC0662-0419 Help People Living With Overweight or Obesity — Tempe, Arizona
• Partnerships for Reducing Overweight and Obesity with Patient-Centered Strategies 2.0 — Boston, Massachusetts
• Impact of Metabolic Health on Sperm Epigenetic Marks in Humans — Boston, Massachusetts
• The Effects of Almond Consumption on Functional Performance and Activity in Overweight Active Older Adults — Tallahassee, Florida

Explore by condition: All Overweight clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.